The high prevalence of kidney failure due to unhealthy
lifestyles has led to the demand of kidney function tests. According to World
Health Organization (WHO), the incidence of chronic kidney disease (CKD) cases is
growing at an 8% rate annually. These tests can determine the probability of
CKD in diabetic or non-diabetics in the early stages.
Kidney Function Tests
Kidney function tests or renal function tests are able to
determine the possibility of CKD and other kidney-related disorders. Different
types of tests include creatinine clearance test, furosemide test, and
glomerular filtration rate (GFR or eGFR) test. Early detection of kidney
failure can prevent the progression of such diseases. Symptoms associated with
such medical disorders are hypertension, frequent urge to urinate, and swelling
of hands and feet.
View summary of this report, Click Here
Developments
The United States Food & Drug Administration (FDA) recently
approved the marketing of a noninvasive test to determine membranous
glomerulonephritis (MGN) to EUROIMMUN US, Inc., a US-based company. MGN is a
disease which affects the glomeruli in the kidney.
Proteomics International Limted, an Australian life sciences
company, launched a prognostic test to determine the possibility of diabetic
kidney disease (DKD). The information can be gained with the help of a blood
sample test to identify at-risk groups and provide timely treatment to prevent its
progression.
Market Overview
The worldwide kidney function tests market is projected at
nearly USD 2 billion by 2025, according to Grand View Research, Inc. It is
anticipated to grow at a 5.2% CAGR over the forecast period (2014 - 2025). It
is driven by the high prevalence of kidney disorders globally.
Dilution & concentration, imaging, clearance, and urine
tests are products within the market. Clearance tests had gained over 30%
market shares in 2016 to detect the GFR within kidneys. Imaging tests are
anticipated a high CAGR over the forecast period.
Hospitals were the biggest end-user in 2016 on account of their
sophisticated infrastructure and huge patient volume. Diagnostic laboratories
are expected to exhibit a lucrative CAGR during the forecast period. Prominent
market players include Quest Diagnostics, Merck Millipore, Randox Laboratories,
and Siemens Healthineers.
Sample Request of this Report : sales@grandviewresearch.com
ConversionConversion EmoticonEmoticon